On Sunday, August 8, the biopharmaceutical company CanSino Biologics announced through its twitter account that, according to studies conducted, the level of antibodies in people who received its vaccine is close to 70% after 6 months of application. 

 

As a conclusion of further studies, in a preliminary way, CanSino Bio recommends the application of a second dose of the vaccine after that time to significantly improve the immune response.

 

Sources: Newsweek Español, El Financiero